Delivery Order SPE2DB22D3016-SPE2DB26FAAZ9
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $12,901.75 to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 vaccine syringes (0.5 mL). This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by June 27, 2025. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of PREVNAR 20 syringe vaccines (0.5mL) valued at $30,403.64. This firm fixed-price delivery order represents a non-set-aside competitive award with an ultimate completion date of August 28, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (SPE2DX) with...
- The Defense Logistics Agency awarded a delivery order valued at $12,735.59 to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 vaccine in 0.5mL syringes. This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of June 3, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued...
- The Defense Logistics Agency awarded a $92,004.02 delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 vaccine in 0.5ML syringes under a firm fixed-price contract. The award was made on August 12, 2025, with an ultimate completion date of August 13, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. This competitively awarded delivery order carries no set-aside designation and falls under AmerisourceBergen's existing contract vehicle with DLA....
- The Defense Logistics Agency awarded a $86,365.07 delivery order to AmerisourceBergen Drug Corp for the supply of Prevnar 20 syringes (0.5mL) under a firm fixed-price contract type. The award, announced on July 16, 2025, with an ultimate completion date of July 17, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, served as the prime contractor for this medical supply delivery order, which will be performed at the...
- The Defense Logistics Agency awarded a delivery order valued at $2,372.10 to AmerisourceBergen Drug Corp for PREVNAR 20 syringes (0.5mL) with an ultimate completion date of November 3, 2025. This is a firm fixed-price, non-set-aside contract with performance at the awardee's Conshohocken, Pennsylvania location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,535.12 for PREVNAR 20 Syringe 0.5ML on July 11, 2025, with completion scheduled for July 14, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single-line pharmaceutical procurement under the company's broader relationship...
- The Defense Logistics Agency awarded a $40,118.88 delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 syringe supply (0.5mL) under a firm fixed-price contract. The delivery order, issued on September 5, 2025, with an ultimate completion date of September 8, 2025, represents a non-competitive set-aside delivery against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a $78,798.85 delivery order to AmerisourceBergen Drug Corp for Prevnar 20 vaccine in 0.5ML syringes, with an ultimate completion date of July 22, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the vendor's corporate headquarters in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Prevnar 20 syringes (0.5mL) under a firm fixed-price contract valued at $38,637.44. The award, issued on September 26, 2025, with an ultimate completion date of September 29, 2025, represents a non-set-aside competitive procurement. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB26FAAZ9Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $38,098.03 to supply PREVNAR 20 syringes (0.5mL) with an ultimate completion date of November 3, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills a critical role in the federal medical supply chain, particularly supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio of delivery orders with the DLA demonstrates its capability to supply a broad range of pharmaceutical products and medical supplies, including specialty medications, vaccines, and medical devices across multiple therapeutic domains. This specific vaccine supply order supports the military's pharmaceutical procurement needs through a flexible contract mechanism that enables efficient fulfillment of federal medical requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $38.1k | 10/31/25 |